Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiharu Watanabe

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|November 11, 2016
Cavity mode enhancement of terahertz emission from equilateral triangular microstrip antennas of the high-T <sub>c</sub> superconductor Bi<sub>2</sub>Sr<sub>2</sub>CaCu<sub>2</sub>O<sub>8 + δ</sub>Daniel P Cerkoney, Candy Reid, Constance M Doty, et al.
The Journal of Dermatology|May 27, 2021
A phase III, 52-week, open-label study to evaluate the safety and efficacy of 5% sofpironium bromide (BBI-4000) gel in Japanese patients with primary axillary hyperhidrosisTomoko Fujimoto, Yoichiro Abe, Masaru Igarashi, et al.
The Journal of Dermatology|January 7, 2021
A phase 3, multicenter, randomized, double-blind, vehicle-controlled, parallel-group study of 5% sofpironium bromide (BBI-4000) gel in Japanese patients with primary axillary hyperhidrosisHiroo Yokozeki, Tomoko Fujimoto, Yoichiro Abe, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|November 11, 2016
Cavity mode enhancement of terahertz emission from equilateral triangular microstrip antennas of the high-T <sub>c</sub> superconductor Bi<sub>2</sub>Sr<sub>2</sub>CaCu<sub>2</sub>O<sub>8 + δ</sub>Daniel P Cerkoney, Candy Reid, Constance M Doty, et al.
The Journal of Dermatology|May 27, 2021
A phase III, 52-week, open-label study to evaluate the safety and efficacy of 5% sofpironium bromide (BBI-4000) gel in Japanese patients with primary axillary hyperhidrosisTomoko Fujimoto, Yoichiro Abe, Masaru Igarashi, et al.
The Journal of Dermatology|January 7, 2021
A phase 3, multicenter, randomized, double-blind, vehicle-controlled, parallel-group study of 5% sofpironium bromide (BBI-4000) gel in Japanese patients with primary axillary hyperhidrosisHiroo Yokozeki, Tomoko Fujimoto, Yoichiro Abe, et al.
Pageof 2